VANCOUVER, British Columbia, Oct. 13, 2021 (GLOBE NEWSWIRE) -- In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase Velacur TM, the first handheld ...
VANCOUVER, British Columbia, August 12, 2025--(BUSINESS WIRE)--Sonic Incytes Medical Corp, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Velacur ...
VANCOUVER, Nov. 12, 2021 (GLOBE NEWSWIRE) — Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of Velacur TM – the first handheld 3D liver health assessment ...
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) — Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results